Director/PDMR Shareholding
EDX Medical Group plc announced that Professor Sir Christopher Evans, founder and Chief Scientific Officer, purchased 41,780 ordinary shares on January 8, 2026, at 13.00 pence per share, following previous share purchases on January 2 and January 5, 2026. This latest transaction brings his total ownership to 136,161,523 shares, representing 35.22% of the issued share capital.
Select text to share a quote on X · sign in to keep highlights & notes in your EDX notes
CAMBRIDGE, UK: EDX Medical Group plc ("EDX Medical", the "Company" or the "Group"), which develops innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectious diseases, today announces that Professor Sir Christopher Evans, founder and Chief Scientific Officer of the Company, purchased 41,780 ordinary shares in the Company on January 8, 2026, at a price per share of 13.00 pence.
This transaction follows the purchase by Professor Evans of 45,500 ordinary shares in the Company, as announced on January 5, 2026, and the earlier purchase of 57,304 ordinary shares in the Company, as announced on January 2, 2026.
Professor Evans now owns 136,161,523 shares in the Company, representing 35.22% of the issued share capital.
The directors of the Company accept responsibility for the contents of this announcement.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Professor Sir Christopher Evans |
| 2 | Reason for the notification | |
| a) | Position/status | Board Director / Chief Scientific Officer |
| b) | Initial notification /Amendment | Initial notification |
| a) | Name | EDX Medical Group plc |
| b) | LEI | 213800BZVJZTMCZ6DJ63 |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each |
| Identification code | ISIN: GB00BNDMJS47 | |
| b) | Nature of the transaction | Purchase of shares on market |
| c) | Price(s) and volume(s) | |
| Price | Volume | |
| £0.1300 | 41,780 | |
| d) | Aggregated information | |
| - Aggregated volume | 41,780 | |
| - Price | £0.1300 | |
| e) | Date of the transaction | 2026-01-08 |
| f) | Place of the transaction | AQSG - Aquis Growth Market (Equity) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.